location: ONLINE | Date: 10-25-2025
Breast cancer, the most common cancer in women globally, reported new cases and 670,000 deaths in 2022, with incidence rising 1-5% annually in half of countries, fueling over $100 billion in yearly economic costs and social disruptions like workforce losses, disproportionately burdening low- and middle-income nations through late-stage diagnoses and screening gaps. 
Driven by modifiable risks (obesity, alcohol, inactivity—averting up to one-third of cases) and non-modifiable factors (age, genetics like BRCA1/2), early mammography reduces mortality by 20-40%. 
WHO s Global Breast Cancer Initiative targets 70% early diagnosis and 80% treatment access by 2025 via awareness campaigns, subsidized screenings, equitable therapies, and AI/vaccines however, geographic disparities, stigma, underfunding, and low uptake—amid projections of 38% incidence and 68% mortality rises by 2050—highlight the need for urgent international collaboration, policy advocacy, and education to elevate survival rates to 80-90% in high-resource settings.